{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:35:43Z","timestamp":1792636543928,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13311-021-01127-1","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T15:39:26Z","timestamp":1634657966000},"page":"2324-2336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?"],"prefix":"10.1016","volume":"18","author":[{"given":"Guido","family":"Cavaletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Marmiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia L.","family":"Renn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pina","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Quartu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Meregalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-021-01127-1_bib1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1007\/s13311-021-01127-1_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/14656566.2017.1415326","article-title":"Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity","volume":"19","author":"Cavaletti","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"10.1007\/s13311-021-01127-1_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14737175.2020.1796639","article-title":"Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms","volume":"20","author":"Argyriou","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"10.1007\/s13311-021-01127-1_bib4","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1007\/s13311-021-01127-1_bib5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: A current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-021-01127-1_bib6","doi-asserted-by":"crossref","unstructured":"Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 2012;14 Suppl 4:iv45\u201354.","DOI":"10.1093\/neuonc\/nos203"},{"issue":"Suppl 2","key":"10.1007\/s13311-021-01127-1_bib7","first-page":"S6","article-title":"Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue","volume":"24","author":"Cavaletti","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"10.1007\/s13311-021-01127-1_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/WCO.0000000000000724","article-title":"Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity","volume":"32","author":"Alberti","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-021-01127-1_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-021-01127-1_bib10","unstructured":"Lu HC, Mackie K. Review of the Endocannabinoid System. Biol Psychiatry Cogn Neurosci Neuroimaging 2020 (online ahead of print)"},{"key":"10.1007\/s13311-021-01127-1_bib11","doi-asserted-by":"crossref","unstructured":"Riquelme-Sandoval A, de S\u00e1-Ferreira CO, Miyakoshi LM, Hedin-Pereira C. New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling. Front Pharmacol 2020;11:596572.","DOI":"10.3389\/fphar.2020.596572"},{"key":"10.1007\/s13311-021-01127-1_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","article-title":"The cannabinoid receptors","volume":"68\u201369","author":"Howlett","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1007\/s13311-021-01127-1_bib13","doi-asserted-by":"crossref","unstructured":"Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161\u2013202.","DOI":"10.1124\/pr.54.2.161"},{"key":"10.1007\/s13311-021-01127-1_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","article-title":"Mechanisms of signalling and biased agonism in G protein-coupled receptors","volume":"19","author":"Wootten","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1007\/s13311-021-01127-1_bib15","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3390\/ijms21207693","article-title":"Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases","volume":"21","author":"Haspula","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-021-01127-1_bib16","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1523\/JNEUROSCI.0442-05.2005","article-title":"Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types","volume":"25","author":"Bodor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-021-01127-1_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-20825-1_3","article-title":"Distribution of the Endocannabinoid System in the Central Nervous System","volume":"231","author":"Hu","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1007\/s13311-021-01127-1_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neuroscience.2005.01.026","article-title":"CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons","volume":"136","author":"Ny\u00edri","year":"2005","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-021-01127-1_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2008.01.029","article-title":"Endocannabinoids mediate neuron-astrocyte communication","volume":"57","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"key":"10.1007\/s13311-021-01127-1_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"key":"10.1007\/s13311-021-01127-1_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1007\/s13311-021-01127-1_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1007\/s13311-021-01127-1_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-319-20825-1_6","article-title":"Endocannabinoids and the Immune System in Health and Disease","volume":"231","author":"Cabral","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1007\/s13311-021-01127-1_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-021-01127-1_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuropharm.2018.07.002","article-title":"Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation","volume":"139","author":"Mulpuri","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-021-01127-1_bib26","doi-asserted-by":"crossref","first-page":"5234943","DOI":"10.1155\/2018\/5234943","article-title":"Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models","volume":"2018","author":"Masocha","year":"2018","journal-title":"Pain Res Manag"},{"key":"10.1007\/s13311-021-01127-1_bib27","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1111\/bph.13887","article-title":"Single and combined effects of \u0394","volume":"174","author":"King","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-021-01127-1_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/acsptsci.9b00008","article-title":"Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain","volume":"2","author":"Sierra","year":"2019","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1007\/s13311-021-01127-1_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jpain.2018.10.007","article-title":"Cannabinoid Type 2 Receptor System Modulates Paclitaxel-Induced Microglial Dysregulation and Central Sensitization in Rats","volume":"20","author":"Wu","year":"2019","journal-title":"J Pain"},{"key":"10.1007\/s13311-021-01127-1_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1055\/s-0042-106303","article-title":"Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice","volume":"82","author":"Harris","year":"2016","journal-title":"Planta Med"},{"key":"10.1007\/s13311-021-01127-1_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/mol.115.098483","article-title":"CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1\/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain","volume":"88","author":"Deng","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1007\/s13311-021-01127-1_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"key":"10.1007\/s13311-021-01127-1_bib33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-021-01127-1_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00474-7","article-title":"The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain","volume":"92","author":"Fox","year":"2001","journal-title":"Pain"},{"key":"10.1007\/s13311-021-01127-1_bib35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm0915-966","article-title":"Cannabinoid receptor with an \u2018identity crisis\u2019 gets a second look","volume":"21","author":"Rogers","year":"2015","journal-title":"Nat Med"},{"key":"10.1007\/s13311-021-01127-1_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-021-01127-1_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-021-01127-1_bib38","doi-asserted-by":"crossref","unstructured":"Makker PG, Duffy SS, Lees JG, et al. Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy. PLoS One 2017;12:e0170814.","DOI":"10.1371\/journal.pone.0170814"},{"key":"10.1007\/s13311-021-01127-1_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(00)00307-6","article-title":"In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors","volume":"109","author":"Sacerdote","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-021-01127-1_bib40","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0022-3565(25)09609-0","article-title":"delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages","volume":"273","author":"McCoy","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-021-01127-1_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(02)00370-3","article-title":"Delta 9-Tetrahydrocannabinol regulates Th1\/Th2 cytokine balance in activated human T cells","volume":"133","author":"Yuan","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-021-01127-1_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.102.033506","article-title":"Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo","volume":"302","author":"McKallip","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-021-01127-1_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2018.09.029","article-title":"Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models","volume":"840","author":"Chiorazzi","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-021-01127-1_bib44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4161\/cc.27476","article-title":"Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy","volume":"13","author":"Meregalli","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1007\/s13311-021-01127-1_bib45","doi-asserted-by":"crossref","unstructured":"Quartu M, Carozzi VA, Dorsey SG, et al. Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve. Biomed Res Int 2014;2014:180428.","DOI":"10.1155\/2014\/180428"},{"key":"10.1007\/s13311-021-01127-1_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Experimental Neurology"},{"key":"10.1007\/s13311-021-01127-1_bib47","first-page":"151","article-title":"CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats","volume":"5","author":"Meregalli","year":"2012","journal-title":"J Pain Res"},{"key":"10.1007\/s13311-021-01127-1_bib48","first-page":"5453","article-title":"Antibody against tumor necrosis factor-\u03b1 reduces bortezomib-induced allodynia in a rat model","volume":"33","author":"Chiorazzi","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1007\/s13311-021-01127-1_bib49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12974-018-1270-x","article-title":"High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats","volume":"15","author":"Meregalli","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-021-01127-1_bib50","doi-asserted-by":"crossref","unstructured":"Carozzi VA, Renn CL, Bardini M, et al. Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse. PLoS One 2013;8:e72995.","DOI":"10.1371\/journal.pone.0072995"},{"key":"10.1007\/s13311-021-01127-1_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1744-8069-7-29","article-title":"Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice","volume":"7","author":"Renn","year":"2011","journal-title":"Mol Pain"},{"key":"10.1007\/s13311-021-01127-1_bib52","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.pain.2008.06.007","article-title":"Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons","volume":"138","author":"Anand","year":"2008","journal-title":"Pain"},{"key":"10.1007\/s13311-021-01127-1_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1744-8069-6-82","article-title":"Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons","volume":"6","author":"Anand","year":"2010","journal-title":"Mol Pain"},{"key":"10.1007\/s13311-021-01127-1_bib54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","article-title":"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain","volume":"47","author":"Lynch","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"10.1007\/s13311-021-01127-1_bib55","first-page":"1019","article-title":"Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial","volume":"26","author":"Kleckner","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1007\/s13311-021-01127-1_bib56","doi-asserted-by":"crossref","first-page":"E172","DOI":"10.1097\/NCC.0000000000000801","article-title":"Exercise Effects on Chemotherapy-Induced Peripheral Neuropathy: A Comprehensive Integrative Review","volume":"43","author":"Kanzawa-Lee","year":"2020","journal-title":"Cancer Nurs"},{"key":"10.1007\/s13311-021-01127-1_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11912-020-00903-0","article-title":"The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy","volume":"22","author":"Tofthagen","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1007\/s13311-021-01127-1_bib58","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.psyneuen.2011.09.017","article-title":"Intense exercise increases circulating endocannabinoid and BDNF levels in humans\u2013possible implications for reward and depression","volume":"37","author":"Heyman","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1007\/s13311-021-01127-1_bib59","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00421-012-2495-5","article-title":"Exercise-induced endocannabinoid signaling is modulated by intensity","volume":"113","author":"Raichlen","year":"2013","journal-title":"Eur J Appl Physiol"},{"key":"10.1007\/s13311-021-01127-1_bib60","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Aranda F, Sauchelli S, Pastor A, et al. Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament. PLoS One 2014;9(8):e104534.","DOI":"10.1371\/journal.pone.0104534"},{"key":"10.1007\/s13311-021-01127-1_bib61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1249\/MSS.0b013e3182a10ce6","article-title":"The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects","volume":"46","author":"Gasperi","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"10.1007\/s13311-021-01127-1_bib62","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jpain.2014.09.006","article-title":"Mechanisms of exercise-induced hypoalgesia","volume":"15","author":"Koltyn","year":"2014","journal-title":"J Pain"},{"key":"10.1007\/s13311-021-01127-1_bib63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.psyneuen.2016.09.014","article-title":"Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans","volume":"74","author":"Cedernaes","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1007\/s13311-021-01127-1_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1212\/WNL.0000000000006083","article-title":"Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations","volume":"91","author":"Gewandter","year":"2018","journal-title":"Neurology"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01127-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:41:27Z","timestamp":1761806487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923007055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1878747923007055"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01127-1","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01127-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The authors. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}